Rabies – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Rabies – Drugs In Development, 2024 report and make more profitable business decisions.
Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of feeling in an area of the body, loss of muscle function, difficulty swallowing, excitability, fever, and convulsions. The predisposing factors include exposure to wildlife and exposure to pets that are not vaccinated.
The Rabies drugs in development market research report provide comprehensive information on the therapeutics under development for Rabies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rabies and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Rabies | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 66 molecules, with 56 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Rabies therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Rabies pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Rabies treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AIM Vaccine Co LtdAstriVax NV
Beijing Minhai Biotechnology Co Ltd
Biocytogen Pharmaceuticals (Beijing) Co Ltd
Changchun Bcht Biotechnology Co Ltd
Chengdu Institute of Biological Products Co Ltd
Chengdu Rongsheng Pharmaceutical Co Ltd
China Medical System Holdings Ltd
Chongqing Zhifei Biological Products Co Ltd
Clover Biopharmaceuticals Ltd
CPL Biologicals Pvt Ltd
Curative Biotechnology Inc
Curevac NV
Dalian Ya Li-feng Biological Pharmaceutical Co Ltd
Everest Medicines Ltd
Genrix (Shanghai) Biopharmaceutical Co Ltd
Immorna Hangzhou Biotechnology Co Ltd
Indian Immunologicals Ltd
Jiangsu Ab&b Bio-tech Co Ltd
Jiangsu Kangrun Biological Technology Co Ltd
Jiangsu Xiansheng Weike Biopharmaceutical Co Ltd
Lankenau Institute for Medical Research
Lanzhou Institute of Biological Products Co Ltd
Leiden University Medical Center
Liaoning Cheng Da Biotechnology Co Ltd
Longuide Limited Lab
MAXVAX Biotechnology Co Ltd
Molecular Targeting Technologies Inc
Oita University Institute of Advanced Medicine Inc
Prosetta Biosciences Inc
Real Benefitspot Pharmaceutical Co Ltd
Replicate Bioscience Inc
Sanofi
Shandong Yidu Biotechnology Co Ltd
Shanghai Bovax Biotechnology Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Shanghai Qingsai Biotechnology Co Ltd
Shanghai Rongsheng Biotech Co Ltd
Shenzhen Weiguang Biological Products Co Ltd
Stemirna Therapeutics Ltd
Suzhou Abogen Biosciences Co Ltd
Synermore Biologics Co Ltd
The National Institute of Allergy and Infectious Diseases
Thomas Jefferson University
University of Maryland
University of Oxford
Vanderbilt University
Vir Biotechnology Inc
Wistar Institute
Wuhan Binhui Biopharmaceutical Co Ltd
Wuhan Institute Of Virology
Yisheng Biopharma Co Ltd
Zhejiang Pukang Biotechnology Co Ltd
Zhuhai Trinomab Biotechnology Co Ltd
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Rabies reports